Arcutis Biotherapeutics, Inc. ARQT Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| —— | -$140.04M+46.6% | -$262.14M+15.8% | -$311.46M-50.9% | ||
| $40.36M-3.3% | $41.73M+7.5% | $38.81M+18.8% | $32.68M+36.8% | ||
| —— | -$112.16M+54.6% | -$247.06M+4.1% | -$257.72M-47.6% | ||
| —— | $143K-66.6% | $428K+28.5% | $333K-66.5% | ||
| -$30.25M-205% | $28.82M— | —— | —— | ||
| $0-100% | $100M— | $0— | $0— | ||
| $6.97M— | —— | $101.32M-66.4% | $301.8M+7.0% | ||
| -$28.74M-65.4% | -$17.37M— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Arcutis Biotherapeutics, Inc. generate?
- Arcutis Biotherapeutics, Inc. (ARQT) generated -$30.6M in operating cash flow over the trailing twelve months.
- What is Arcutis Biotherapeutics, Inc.'s free cash flow?
- After $686.0K of capital expenditures, Arcutis Biotherapeutics, Inc.'s free cash flow was -$31.3M over the trailing twelve months, up 81.4% year over year.
- Where does Arcutis Biotherapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Arcutis Biotherapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
